Open AccessTucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer
Author(s) -
R.K. Murthy,
S. Loi,
A. Okines,
E. Paplomata,
E. Hamilton,
S.A. Hurvitz,
Naiheng Lin,
VITÓRIA CAMILLY ROCHA BORGES,
V. Abramson,
C. Anders,
P.L. Bedard,
M. Oliveira,
E. Jakobsen,
T. Bachelot,
S.S. Shachar,
Vera Lúcia Machado Müller,
S. Braga,
F.P. Duhoux,
R. Greil,
David Cameron,
L.A. Carey,
G. Curigliano,
K. Gelmon,
G. Hortobagyi,
I. Krop,
S. Loibl,
M. Pegram,
D. Slamon,
M.C. Palanca-Wessels,
L. Walker,
Weiguo Feng,
E.P. Winer
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/exjr-aa22
Subject(s) - capecitabine , trastuzumab , metastatic breast cancer , oncology , medicine , breast cancer , cancer , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom